Founder & CEO

Ollwyn Moran M.Ed

Ollwyn Moran, a distinguished Neuropsychology and Neurophysiology Clinician with over two and a half decades of experience, is a leading media advocate for addressing the pressing physical and cognitive development challenges faced by today’s youth, largely stemming from excessive device exposure and changes in our environments.

Latest Media

Co-Founder & Director

Niall Norton

  • Seasoned commercial leader in complex technology businesses.
  • Advisor and Mentor. Board Member. Business innovator with focus on scaling organisations.
  • Former General Manager at Amdocs and President of Amdocs Networks.
  • Former CEO at Openet Telecoms.
  • Former CFO at O2 (acquired by Telefonica).
Contact

About Us

In response to the alarming rise in issues such as delayed development, poor motor skills, mobility impairments, and myopia, Ollwyn has innovated a range of award winning, patented and scientifically-backed products designed to stimulate essential brain and body functions in children and adolescents.

Recent scientific advancements reveal that these solutions are also effective for adults in recovery, seniors aiming to mitigate age-related cognitive decline, and athletes seeking enhanced performance through improved neurological stimulation.

CogniTherapeutics Limited, co-founded by Ollwyn Moran and Niall Norton, offers specialised product lines under the trade names “Cognikids” for children and “Cognicares” for adults. As developmental gaps widen, the demand for effective products has never been greater, with an estimated total addressable market (TAM) of 95 million products annually in global markets. Our offerings stand out due to their rigorous scientific foundation and high-quality manufacturing.

Minding Minds with CogniTherapeutics

Scientific research confirms what many observe: excessive screen use and reduced physical activity are impacting motor skills, mobility, and vision health across age groups, contributing to delayed development, cognitive challenges and contributing to phenomena like myopia, attention disorders and neurological issues that extend into adulthood. CogniTherapeutics are pioneering solutions, blending 25 years of neuroscience with user-centric design, developing research-backed products that enhance brain and motor function. Recommended
by healthcare and medical professionals. Our products help people of all ages – from infants through to older people. We want people to be aware of, and to use, our products and services immediately as these will help everyone to achieve their potential. We would like your support to help with this important mission.

In parallel we are developing a groundbreaking app to address the increasing reliance on online resources for child development guidance, which are often confusing or inadequate. This service offers essential, best-practice developmental insights and progress tracking, uniquely featuring a guide on primitive and postural reflexes, along with motor, cognitive and emotional milestones.
Designed in Ireland, and manufactured overseas to world class standards – very much borrowing from the Apple model. Our competitive edge lies in the scientific foundation of our products, which are not only technically advanced but also aesthetically pleasing. We have innovated within existing large markets (and categories) to offer unique and special solutions. Our products are simple, easy to use, and beautifully designed, but it is the unseen science that truly sets them apart. With 25 years of expertise in neurological development, our products provide the necessary inputs to build grip strength and fine motor skills —key indicators of brain health. CogniTherapeutics is currently seeking support to expand its footprint in both child and adult markets. We invite you to join us in this significant and promising venture, one that not only has the potential for substantial financial returns but also offers meaningful contributions to societal well-being.
Over-use of modern devices and technology combined with reduced physical activity can adversely impact brain development, leading to challenges in cognition and motor skills. The key to addressing these issues is in building and maintaining motor skills at every stage of life - so that everyone can reach their full potential.
The market for products and advice promoting cognitive function development and maintenance is extensive, encompassing both children and adults.
CogniTherapeutics addresses these needs with expertly designed physical and digital products for effective brain development. We believe that supporting Cognitherapeutics Limited offers a compelling business case for the healthcare industry, and a great commercial and marketing case for larger organisations as this is a unique chance to support a venture dedicated to enhancing cognitive health and well-being. Much as people have become aware that over-indulgence of processed food led to bad physical outcomes, overindulgence in online activities is recognised as being potentially harmful. Investing in Cognitherapeutics Limited will help address this problematic trend.
Let’s tackle this together.